New-onset Intermittent Explosive Disorder (IED); metabolic and clinical correlates: Case report
DOI:
https://doi.org/10.6092/2282-1619/2017.5.1623Keywords:
Intermittent Explosive Disorder, Diabetes Mellitus, Metabolic alterationsAbstract
This paper presents the correlation between Intermittent Explosive Disorder (IED), listed in the domain of Disruptive, Impulse-Control and Conduct Disorders in the Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM 5), and metabolic alterations. A 64-years-old man with no previous history of major psychiatric disorders, presenting an onset of IED almost concomitant with the diagnosis of diabetes mellitus and dyslipidemia, is assessed upon a clinical and neuropsychological evaluation. Authors emphasize the influence of metabolic alterations and liver disease in the manifestation of impulsive aggression and violent behaviour, suggesting a multidisciplinary approach of those patients who present IED and concomitant metabolic alterations.
References
1. Adams WK, Sussman JL, Kaur S, D‟Souza AM, Kieffer JJ, Winstanley CA. Long-term, calorie-restricted intake of a high-fat diet in rats reduces impulse control and ventral striatal D2 receptor signalling: two markers of addiction vulnerability. Eur. J. Neuroscience 2015;42(12):3095-3104.
2. Barratt E.S., 2000: “Barratt Impulsiveness Scale, Version 11 (BIS 11)”, Handbook of psychiatric measures. Washington, DC: American Psychiatric Association; 2000. p. 691 – 3.
3. Bruno Copio Fabregas M. D., Abreu M. N. S., Dantas dos Santos A. K., Moura A.S., Carmo R. A., Teixeira A. L., 2013: “Impulsiveness in chronic hepatitis C patiens”, General Hospital Psychiatry 36 (2014) 261 – 265.
4. Coccaro EF. Intermittent explosive disorder as a disorder of impulsive aggression for DSM-5. Am J Psychiatry 2012;169(6):577-588.
5. Coccaro EF, Lee R, Coussons-Read M. Elevated plasma inflammatory markers in individuals with IED and correlation with aggression in humans. JAMA Psychiatri., 2014; 7(2): 158-165.
6. Conklin S. M., Harris J. I., Manuck S. B., Yao J. K., Hibbeln J. R., Muldoon M. F., 2006: “Serum Ω - 3 fatty acids are associated with variation in mood, personality and behaviour in hypercholesterolemic community volunteers”, Science Direct. Psychiatry Research 152 (2007) 1-10.
7. Freeman M.P., 2000: “Omega – 3 fatty acids in psychiatry: a review”. Annals of Clinical Psychiatry 12, 159-165.
8. Hallan B., Garland M., 2004: Essential fatty acids and their role in the treatment of impulsivity disorders, Prostaglandins, Leukotrienes and Essential Fatty Acids 71, 211-216.
9. Hibbeln J.R., Salem Salem N. Jr, 1995: “Dietary polyunsatured fatty acids and depression: when cholesterol does not satisfy”, American Journal of Clinical Nutrition 62, 1-9.
10. Huang TL, Chen JF. Cholesterol and lipids in depression: stress, hypothalamo-pituitary-adrenocortical axis, and inflammation/immunity. Adv Clin Chem. 2005; 39:81-105.
11. Kessler RC, Coccaro EF, Fava M, Jaeger S, JIn R, Walters E. The prevalence and correlates of DSM-IV intermittent explosive disorder in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2006; 63:669-78.
12. Loas G, Dalleau E, Lecointe H, Yon V. Relationships between anhedonia, alexithymia, impulsivity, suicidal ideation, recent suicide attempt, C-reactive protein and serum lipid levels among 122 inpatients with mood or anxious disorders. Psychiatry Res 2016;246:296-302.
13. Logan A.C., 2003: “Neurobehavioral aspects of omega – 3 fatty acids: possible mechanisms and therapeutic value in major depression.” Alternative Medicine Review 8, 410-425.
14. McCloskey MS, Lee R, Berman ME, Noblett KL, Coccaro EF: The relationship between impulsive verbal aggression and intermittent explosive disorder. Aggress Behav 2008; 34:51–60.
15. McNair D. M., 1971: “Manual of profule mood states”, Edaucational & Industrial Testing Service.
16. Mondini S., Mapelli D., Vestri A., Bisacchi P., 2003: “ENB Esame neuropsicologico breve”, Raffaello Cortina, MI.
17. Paavola P., Repo-Tiihonen E., Tiihonen J. “Serum lipid levels and violence among Finnish male forensic psychiatric patients”. J Forensic Psychiatry, 2002; 13(3):555–568
18. Peet M. and Stokes C., 2005: “Omega – 3 fatty acids in the treatment of psychiatric disorders”, Drug 65, 1051-1059.
19. Richardson A.J., Puri B.K., 2002: “A randomized double-blind, placebo controlled study of the effects of supplementation with highly unsatured fatty acids on ADHD related symptoms in children with specific learning difficulties”, Progress in Neuro-psychopharmacology and Biological Psychiatry 26, 233-239.
20. Shelton R.C., Miller A.H., 2010: “Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression,”, Prog. Neurobiol. 91, 275-299.
21. Sonawalla S. B., Papakostas G. I., Petersen T. J., Yeung A. S., Smith M. M., Sikinger A. H., Gordon J., Isrel J. A., Tedlow J. R., Lamon – Fava A., Fava M., 2002: “Elevated Cholesterol levels associated with nonresponse to fluoxetine treatment in major depressive disorder”. Psychosomatics 43, 310-316.
22. Spielberg C.D., Gorsuch R.C., Lushene R.E., Vagg P.R., Jacobs G.A., 1983: “Manual of State-Trait Anxiety Inventory”, Paolo Alto: consulting Psychologists Press.
23. Strekalova T., Evans M., Costa-Nunes J., Bachurin S., Yeritsyan N., Couch Y, Steinbusch H. M. W., Kohler E., Lesch K. P., Anthony D. C., 2014: “Tlr4 upregulation in the brain accompanies depression- and anxiety-like behaviours induced by a high-cholesterol diet”, Brain Behavior and Immunity 48 (2015) 42 -47.
24. Sutin K, Cutler RG, Camandola S, Uda M, Feldman NH, Cucca F. Impulsivity is associated with uric acid: evidence from humans and mice. Biol. Psych., 2014; 75(1): 31-37.
Downloads
Published
Issue
Section
License
Articles and conference papers published in Mediterranean Journal of Clinical Psychology are distributed under the terms and conditions of a Creative Commons Attribution 4.0 Unported License. Correspondingly, authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).